Investigations on possible role of MIF gene polymorphism in progression of chikungunya infection into cases of acute flaccid paralysis and chronic arthropathy

Journal of Genetics

Volumn 88, Issue 1, 2009, Pages 123-125

  Fulsundar, Shweta Ramdas ^a   Roy, Subarna ^a   Manimunda, Sathya Prakash ^a   Singh, Shiv Shankar ^b   Sugunan, A P ^a   Vijayachari, Paluru ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b Govind Ballabh Pant Hospital   (India)

Author keywords

Acute flaccid paralysis; Arthritis; Chikungunya; Chronic arthropathy; Human genetics; MIF gene

Indexed keywords

ISOMERASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MIF PROTEIN, HUMAN;

ARTHRALGIA; ARTICLE; CHIKUNGUNYA ALPHAVIRUS; CHRONIC DISEASE; COHORT ANALYSIS; DISEASE COURSE; GENETIC POLYMORPHISM; GENETICS; HUMAN; INDIA; PARAPLEGIA; PATHOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS INFECTION;

ALPHAVIRUS INFECTIONS; ARTHRALGIA; CHIKUNGUNYA VIRUS; CHRONIC DISEASE; COHORT STUDIES; DISEASE PROGRESSION; HUMANS; INDIA; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; PARAPLEGIA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 69449103237     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-009-0019-9     Document Type: Article

References (20)

1. Barton A., Lamb R., Symmons D., Silman A., Thomson W., Worthington J. and Donn R. 2003 Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immunol. 4, 487-491.
2. Barton A., Salway F., Thomson W., Silman A., Ollier W., Worthington J. et al. 2002 MIF polymorphism is associated with susceptibility to inflammatory arthritis. Rheumatology 41 (suppl. 1), 126.
3. Baugh J. A. and Bucala R. 2002 Macrophage migration inhibitory factor. Crit. Care Med. 30, 27-35.
4. Baugh J. A., Chitnis S., Donnelly S. C., Monteiro J., Lin X., Plant B. J. et al. 2002 A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 3, 170-176.
5. De Benedetti F., Meazza C., Vivarelli M., Rossi F., Pistorio A., Lamb R., Lunt M. et al. 2003a Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 48, 1398-1407.
6. De Benedetti F., Vivarelli M., Lamb R., Meazza C., Muratori F., Cioschi S. et al. 2003b Association of the -173 SNP of the macrophage migration inhibitory factor (MIF) gene with response to intra-articular glucocorticoids in oligoarticular JIA. Arthritis Rheum. 48, 254.
7. De Jong Y. P., Abadia-Molina A. C., Satoskar A. R., Clarke K., Rietdijk S. T., Faubion W. A. et al. 2001 Development of chronic colitis is dependent on the cytokine MIF. Nat. Immunol. 2, 1061-1066.
8. Donn R., Alourfi Z., De Benedetti F., Meazza C., Zeggini E., Lunt M. et al. 2002 Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 46, 2402-2409.
9. Donn R. P. and Ray D. W. 2004 Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key nueroendocrine molecule. J. Endocrinol. 182, 1-9.
10. Lolis E. 2001 Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. Curr. Opin. Pharmacol. 1, 662-668.
11. Manimunda S. P., Singh S. S., Sugunan A. P., Singh O., Roy S., Shriram A. N. et al. 2007 Chikungunya fever, Andaman and Nicobar Islands, India. Emerg. Infect. Dis. 13, 1259-1260.
12. Matsumoto K. and Kanmatsuse K. 2001 Increased production of macrophage migration inhibitory factor by T cells in patients with IgA nephropathy. Am. J. Nephrol. 21, 455-464.
13. Meazza C., Travaglino P., Pignatti P., Magni-Manzoni S., Ravelli A., Martini A. et al. 2002 Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum. 46, 232-237.
14. Morand E. F., Leech M., Weedon H., Metz C., Bucala R. and Smith M. D. 2002 Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology 41, 558-562.
15. Murakami H., Akbar S. M., Matsui H. and Onji M. 2001 Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur. J. Clin. Invest. 31, 337-343.
16. Niino M., Ogata A., Kikuchi S., Tashiro K. and Nishihira J. 2000 Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behcet's disease. J. Neuroimmunol. 179, suppl. 127-131.
17. Plant B. J., Gallagher C. G., Bucala R., Baugh J. A., Chappell S., Morgan L. et al. 2005 Am. J. Respir. Crit. Care Med. 172, 1412-1415.
18. Sakai Y., Masamune A., Satoh A., Nishihira J., Yamagiwa T. and Shimosegawa T. 2003 Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology 124, 725-736.
19. Zhong Xiao-bo., Leng L., Beitin A., Chen R., McDonald C., Hsiao B. et al. 2005 Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res. 33, e121.
20. Yabunaka N., Nishhira J., Mizue Y., Tsuji M., Kumagai M., Ohtauka Y. et al. 2000 Elevated serum content of Macrophage migration inhibitory factor in patients with type 2 diabetes. Diabetes Care 23, 256-258.